Monica

[Monica @ChinaBiotech]

Trends in innovative drug development in China https://t.co/42Ase0tyPG

[Interdisciplinary Research Leaders @IRLeaders]

We're helping #LeadCommunityChange

Join Us!

https://t.co/PhCzXksYEr

@CSPfellows @jomoworks @blackbeltsista @SMRDI1 @ccdworldwide @magreen422 @TaraOakman @CokerAppiah @sarahgollust @URMC_Recovery @GwensGirlsPgh @lauriegerrell @natalie4health @ClarkMPeters @zinzinator

[Jian (Lily) Chen 陈健 @lilyjianchen]

Starting now ! Please join @Grace4NY @gonggershowitz and other amazing advocates and leaders for this amazing conversation ! #aapi please use this linkhttps://us02web.zoom.us/j/82107220675?pwd=ZVlNdElUKzg3Z2U1VXhlbDJBQkJ0UT09 to join in the meeting

[Monica @ChinaBiotech]

Interesting article on China's data ambitions: China and Big Tech: Xi’s blueprint for a digital dictatorship https://t.co/ieA65LgVSv

[Monica @ChinaBiotech]

AmCham Trying to Reopen in Southwest China After Abrupt Closure - interesting development in light of China’s new NGO law. https://t.co/kV7GSjUTEc

[Xi Chen | 陈希 @xcyale]

The #COVID19 pandemic and the transformation of health policy

Invited perspective on health policy responses in China, the US and beyond to the once-in-a-century changes to human society. @YaleSPH https://t.co/xg5sTghjn6
Ungated full paper: https://t.co/vEH84giBOy 1/3

[Monica @ChinaBiotech]

Commemorating the 50th anniversary of Henry Kissinger’s secret trip to #China. Happy to join event hosted by @NCUSCR with Dr Kissinger & China VP Wang Qishan virtually at DiaoYuTai.

[Rush Doshi @RushDoshi]

Logging on for the first time in months to share some exciting news!

My first book, The Long Game: China's Grand Strategy to Displace American Order, will be out July 8, 2021.

https://t.co/mXOwg2Hw7y

[Monica @ChinaBiotech]

Okay…. Kind of an interesting combination……

[Taiwan News @TaiwanNewsEN]

Pizza Hut Taiwan unleashes cilantro century egg pig's blood cake pizza https://t.co/C5XsX5ae8s

[Meindert Boysen @boysenmh]

Lift off … the HTAi virtual annual meeting has launched #HTAi2021VirtualAM

[Amgen 🧪🔬🧬 @Amgen]

Pandemic-driven missed diagnoses have a big impact on everything from routine screenings to diagnosis and care.

Join a panel of experts for a discussion on that impact on lung cancer that will include insights from a new @IQVIA_Institute report, Lung Cancer Won’t Wait.

[Monica @ChinaBiotech]

Hung Jury.

[Biotechnology Innovation Organization @IAmBiotech]

#IP is a tool for enabling #innovation, development, and commercialization, says Lisa Jorgenson Deputy Director General, #Patents and #Technology, at @WIPO #BIODigital

[Monica @ChinaBiotech]

We are laser focused on… leveraging global drug development in both China & US... by conducting complementary clinical trials in both, sharing clinical data... to reduce development time, accelerate patient access & speed time to market: per Neil Warma of @IMabBiopharma

[Monica @ChinaBiotech]

Great #China panel at #BIODigital: We need continued progress to build a policy environment that incentivizes investments & partnerships for innovation in China - also a value-based payment system that rewards #innovation and facilitates #patientaccess, per My Linh Kha of @Amgen

[Monica @ChinaBiotech]

#China’s volume-based procurement bidding shows that when you lose #intellectualproperty protection in China, the price can go down 90-95% or even more. This highlights the importance of IPR in China, per Tony Chen of @JonesDay

[Monica @ChinaBiotech]

Great #China panel at #BIODigital: We need continued progress to build a policy environment that incentivizes investments & partnerships for innovation in China - also a value-based payment system that rewards #innovation and facilitates #patientaccess, per My Linh Kha of @Amgen

[Monica @ChinaBiotech]

US and China have a tremendous track record on collaboration in science & technology... produced a cornucopia of good over the last 40 yrs. But in the current environment, we cannot for one second take this for granted. Will it continue? asked Amb Craig Allen of @USChinaBusiness

[Monica @ChinaBiotech]

Great #China panel at #BIODigital: We need continued progress to build a policy environment that incentivizes investments & partnerships for innovation in China - also a value-based payment system that rewards #innovation and facilitates #patientaccess, per My Linh Kha of @Amgen

[Biotechnology Innovation Organization @IAmBiotech]

Happening Now: @pfizer leads a convo on #china #biotech sector w/ @USChinaBusiness @JonesDay @Amgen @IMabBiopharma - follow on #BIODigital Live Blog! https://t.co/2Ngm9p6AF0

[Monica @ChinaBiotech]

The potential for #biotechnology to provide solutions to ensure healthy aging in #China & improve quality of life is immense. Join the panel: "Outlook on China’s Biotech Sector: Implications for Collaboration & Global Innovation" at @BIODigital2021
https://t.co/96648shi3e

[Monica @ChinaBiotech]

Great conversation @DrMichelleBIO with @NOIweala, DG of @wto: On the issue of #intellectualproperty, we need a "pragmatic solution" that allows developing countries access to things like vaccines while "incentivizing research." #TRIPSwaiver #BIODigital #innovation